New registry aims to unlock secrets of rare cervical cancer
NCT ID NCT04723095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a registry of 750 people with a rare and aggressive form of cervical cancer called neuroendocrine carcinoma. Researchers will collect information from medical records to learn more about the disease, how it is treated, and what happens to patients over time. The goal is to better understand this cancer and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL LARGE CELL NEUROENDOCRINE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can a smaller dose of this cancer drug still work? new trial aims to find out
- Custom-Made cancer vaccine shows promise in advanced tumors
- Experimental drug plus radiation shows promise for recurrent gynecologic cancers
- New app helps women with advanced cancer fight fear
- New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer